FDA Botanical Review Team To Implement Herbals Guidance, MaPP

The newly formed Botanical Review Team in FDA's Office of New Drugs is intended to "consolidate OND's scientific and regulatory expertise in botanical products," according to a Feb. 20 agency announcement